Sulfasalazine

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A07EC01
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_A07EC01

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 6923 4214 2709
Unadjusted prevalence (%) 2.66 2.87 2.40
Mean age at first event (years) 47.80 46.56 49.72

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.62 [1.28, 2.06] 7.7e-5 443
15 years 0.01 1.84 [1.47, 2.29] 7.6e-8 334
5 years 0.00 2.28 [1.78, 2.91] 4.3e-11 102
1 year - - - -

Correlations

Index endpoint: RX_A07EC01 – Sulfasalazine
GWS hits:

Survival analyses between endpoints

Plot

before Sulfasalazine
after Sulfasalazine

loading spinner Loading survival analyses plot